Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ketorolac
Drug ID BADD_D01232
Description Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.[L6358][L6508][L11055][L3674][L11070] It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.[L6520] Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.[L6511]
Indications and Usage For the short-term (~5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.
Marketing Status Not Available
ATC Code M01AB15; S01BC05
DrugBank ID DB00465
KEGG ID D08104
MeSH ID D020910
PubChem ID 3826
TTD Drug ID D0D9JW
NDC Product Code Not Available
Synonyms Ketorolac
Chemical Information
Molecular Formula C15H13NO3
CAS Registry Number 74103-06-3
SMILES C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Chest pain08.01.08.002; 02.02.02.011; 22.02.08.0030.000919%Not Available
Chromaturia20.02.01.0020.000459%
Colitis07.08.01.001--
Colitis ulcerative10.02.01.004; 07.08.01.005--Not Available
Coma17.02.09.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Conjunctivitis06.04.01.002; 11.01.06.012--
Constipation07.02.02.001--
Corneal erosion06.06.03.003--Not Available
Corneal infiltrates06.08.01.002--Not Available
Corneal oedema06.04.02.001--Not Available
Corneal perforation12.01.04.003; 06.06.03.006--Not Available
Cough22.02.03.0010.000689%
Crohn's disease10.02.01.005; 07.08.01.015--Not Available
Cystitis20.03.02.002; 11.01.14.001--
Deafness04.02.01.001--Not Available
Depressed level of consciousness17.02.04.002--
Dermatitis23.03.04.002--Not Available
Dermatitis exfoliative10.01.01.004; 23.03.07.001--
Diarrhoea07.02.01.001--
Discomfort08.01.08.0030.000459%Not Available
Disturbance in attention19.21.02.002; 17.03.03.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Drug hypersensitivity10.01.01.0010.012861%Not Available
Dry eye06.08.02.001--
Dry mouth07.06.01.002--
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.01.03.0020.001148%
Dysuria20.02.02.002--
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.001--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 8 Pages